Back to 
Schonfeld Strategic Advisors LLC
Schonfeld Strategic Advisors LLC
PLRX
Showing 0 of 5 quarters
Position history for Schonfeld Strategic Advisors LLC's holdings in Pliant Therapeutics, Inc.
No. Schonfeld Strategic Advisors exited its PLRX (Pliant Therapeutics) position in Q2 2023. Its Q1 2023 13F listed 8,582 shares worth $228,281. Schonfeld Strategic Advisors first reported PLRX in Q2 2022 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.